SEC Form 4 · accession 0001209191-18-017523
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven W Spector
Officer — EVP, General Counsel & Sec
Period of report
Mar 2, 2018
Accepted (ET)
Mar 6, 2018 · 7:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 2, 2018 | A | 11,205 | $0.00 | A | 23,564 | D | |
| Common StockF2 | Mar 2, 2018 | F | 3,874 | $42.80 | D | 19,690 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 11, 2015, the Reporting Person was granted performance restricted stock units. On March 2, 2018, it was determined that 11,205 of the shares subject to the grant vested.
- F2The amount represents shares withheld for payment of tax liability relating to vesting of performance restricted stock units.